• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结缔组织生长因子在苯妥英钠、环孢素和硝苯地平所致药物性牙龈增生中作用的免疫组织化学分析

Immunohistochemical Analysis of the Role Connective Tissue Growth Factor in Drug-induced Gingival Overgrowth in Response to Phenytoin, Cyclosporine, and Nifedipine.

作者信息

Anand A J, Gopalakrishnan Sivaram, Karthikeyan R, Mishra Debasish, Mohapatra Shreeyam

机构信息

Department of Periodontics, Tamil Nadu Government Dental College, Chennai, Tamil Nadu, India.

Department of Periodontics, Ragas Dental College and Hospitals, Chennai, Tamil Nadu, India.

出版信息

J Int Soc Prev Community Dent. 2018 Jan-Feb;8(1):12-20. doi: 10.4103/jispcd.JISPCD_403_17. Epub 2018 Feb 6.

DOI:10.4103/jispcd.JISPCD_403_17
PMID:29629324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853037/
Abstract

OBJECTIVE

To evaluate for the presence of connective tissue growth factor (CTGF) in drug (phenytoin, cyclosporine, and nifedipine)-induced gingival overgrowth (DIGO) and to compare it with healthy controls in the absence of overgrowth.

MATERIALS AND METHODS

Thirty-five patients were chosen for the study and segregated into study (25) and control groups (10). The study group consisted of phenytoin-induced (10), cyclosporine-induced (10), and nifedipine-induced (5) gingival overgrowth. After completing necessary medical evaluations, biopsy was done. The tissue samples were fixed in 10% formalin and then immunohistochemically evaluated for the presence of CTGF. The statistical analysis of the values was done using statistical package SPSS PC+ (Statistical Package for the Social Sciences, version 4.01).

RESULTS

The outcome of immunohistochemistry shows that DIGO samples express more CTGF than control group and phenytoin expresses more CTGF followed by nifedipine and cyclosporine.

CONCLUSION

The study shows that there is an increase in the levels of CTGF in patients with DIGO in comparison to the control group without any gingival overgrowth. In the study, we compared the levels of CTGF in DIGO induced by three most commonly used drugs phenytoin, cyclosporine, and nifedipine. By comparing the levels of CTGF, we find that cyclosporine induces the production of least amount of CTGF. Therefore, it might be a more viable drug choice with reduced side effects.

摘要

目的

评估结缔组织生长因子(CTGF)在药物(苯妥英钠、环孢素和硝苯地平)性牙龈增生(DIGO)中的存在情况,并与无牙龈增生的健康对照进行比较。

材料与方法

选择35例患者进行研究,分为研究组(25例)和对照组(10例)。研究组包括苯妥英钠所致(10例)、环孢素所致(10例)和硝苯地平所致(5例)牙龈增生。完成必要的医学评估后,进行活检。组织样本用10%福尔马林固定,然后进行免疫组织化学评估CTGF的存在情况。使用统计软件包SPSS PC+(社会科学统计软件包,版本4.01)对数据进行统计分析。

结果

免疫组织化学结果显示,DIGO样本比对照组表达更多的CTGF,苯妥英钠表达的CTGF最多,其次是硝苯地平,然后是环孢素。

结论

该研究表明,与无牙龈增生的对照组相比,DIGO患者的CTGF水平升高。在该研究中,我们比较了三种最常用药物苯妥英钠、环孢素和硝苯地平所致DIGO中CTGF的水平。通过比较CTGF水平,我们发现环孢素诱导产生的CTGF量最少。因此,它可能是一种副作用较小、更可行的药物选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/d42d1b1e5d7e/JISPCD-8-12-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/ff205e04e042/JISPCD-8-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/7fb931a1ebef/JISPCD-8-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/270c2d270f89/JISPCD-8-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/38c7b92f4aed/JISPCD-8-12-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/b8d2f4fe3394/JISPCD-8-12-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/48a2eab8735b/JISPCD-8-12-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/a562774c732f/JISPCD-8-12-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/791d152679e2/JISPCD-8-12-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/4e2ef52afeea/JISPCD-8-12-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/5dbe43790ba2/JISPCD-8-12-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/5352030bb2e6/JISPCD-8-12-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/db7d4609a900/JISPCD-8-12-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/a1c7e41e666a/JISPCD-8-12-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/f2952cdd24ea/JISPCD-8-12-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/579efe6f7613/JISPCD-8-12-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/2ab3f0ae7281/JISPCD-8-12-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/888ad77e0be5/JISPCD-8-12-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/831a5bcfd669/JISPCD-8-12-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/d42d1b1e5d7e/JISPCD-8-12-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/ff205e04e042/JISPCD-8-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/7fb931a1ebef/JISPCD-8-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/270c2d270f89/JISPCD-8-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/38c7b92f4aed/JISPCD-8-12-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/b8d2f4fe3394/JISPCD-8-12-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/48a2eab8735b/JISPCD-8-12-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/a562774c732f/JISPCD-8-12-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/791d152679e2/JISPCD-8-12-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/4e2ef52afeea/JISPCD-8-12-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/5dbe43790ba2/JISPCD-8-12-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/5352030bb2e6/JISPCD-8-12-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/db7d4609a900/JISPCD-8-12-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/a1c7e41e666a/JISPCD-8-12-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/f2952cdd24ea/JISPCD-8-12-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/579efe6f7613/JISPCD-8-12-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/2ab3f0ae7281/JISPCD-8-12-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/888ad77e0be5/JISPCD-8-12-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/831a5bcfd669/JISPCD-8-12-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958b/5853037/d42d1b1e5d7e/JISPCD-8-12-g029.jpg

相似文献

1
Immunohistochemical Analysis of the Role Connective Tissue Growth Factor in Drug-induced Gingival Overgrowth in Response to Phenytoin, Cyclosporine, and Nifedipine.结缔组织生长因子在苯妥英钠、环孢素和硝苯地平所致药物性牙龈增生中作用的免疫组织化学分析
J Int Soc Prev Community Dent. 2018 Jan-Feb;8(1):12-20. doi: 10.4103/jispcd.JISPCD_403_17. Epub 2018 Feb 6.
2
Connective tissue growth factor in drug-induced gingival overgrowth.药物性牙龈增生中的结缔组织生长因子
J Periodontol. 2001 Jul;72(7):921-31. doi: 10.1902/jop.2001.72.7.921.
3
Immunoexpression of interleukin-6 in drug-induced gingival overgrowth patients.白细胞介素-6在药物性牙龈增生患者中的免疫表达
Contemp Clin Dent. 2016 Apr-Jun;7(2):140-5. doi: 10.4103/0976-237X.183048.
4
Biological roles of KGF, CTGF and TGF-β in cyclosporine-A- and phenytoin- induced gingival overgrowth: A comparative experimental animal study.角质形成细胞生长因子、结缔组织生长因子和转化生长因子-β在环孢素A和苯妥英钠诱导的牙龈过度生长中的生物学作用:一项对比性实验动物研究。
Arch Oral Biol. 2016 Jun;66:38-43. doi: 10.1016/j.archoralbio.2016.02.006. Epub 2016 Feb 11.
5
Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis.牙龈纤维化中上皮和结缔组织细胞的结缔组织生长因子/CCN2表达
J Pathol. 2006 Sep;210(1):59-66. doi: 10.1002/path.2000.
6
Flutamide inhibits nifedipine- and interleukin-1 beta-induced collagen overproduction in gingival fibroblasts.氟他胺抑制硝苯地平和白细胞介素-1β诱导的牙龈成纤维细胞胶原过度产生。
J Periodontal Res. 2010 Aug;45(4):451-7. doi: 10.1111/j.1600-0765.2009.01255.x. Epub 2010 Mar 9.
7
Angiotensin II Levels in Gingival Tissues from Healthy Individuals, Patients with Nifedipine Induced Gingival Overgrowth and Non Responders on Nifedipine.健康个体、硝苯地平诱导的牙龈增生患者及硝苯地平无反应者牙龈组织中的血管紧张素II水平
J Clin Diagn Res. 2015 Aug;9(8):ZC92-4. doi: 10.7860/JCDR/2015/14492.6388. Epub 2015 Aug 1.
8
[Connective tissue growth factors, CTGF and Cyr61 in drug-induced gingival overgrowth--an animal model].[结缔组织生长因子、CTGF和Cyr61在药物性牙龈增生中的作用——动物模型]
Rev Med Chir Soc Med Nat Iasi. 2008 Oct-Dec;112(4):1026-33.
9
Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth.药物性牙龈过度增生的研究趋势和特征的文献计量分析。
Front Public Health. 2022 Sep 6;10:979861. doi: 10.3389/fpubh.2022.979861. eCollection 2022.
10
Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions.药物性牙龈增生-药物作用的分子机制
Int J Mol Sci. 2023 Mar 13;24(6):5448. doi: 10.3390/ijms24065448.

引用本文的文献

1
Antiproliferative effect of low-level laser/ photobiomodulation on gingival fibroblasts derived from calcium channel blocker-induced gingival overgrowth.低水平激光/光生物调节对钙通道阻滞剂诱导的牙龈过度生长中牙龈成纤维细胞的抗增殖作用。
Lasers Med Sci. 2024 Jul 25;39(1):194. doi: 10.1007/s10103-024-04122-y.
2
Improvement of drug-induced gingival overgrowth and cerebrovascular related dementia after dental treatments.牙科治疗后药物性牙龈增生及脑血管相关痴呆的改善情况。
Clin Case Rep. 2023 Oct 23;11(10):e8093. doi: 10.1002/ccr3.8093. eCollection 2023 Oct.

本文引用的文献

1
Gingival hyperplasia: Should drug interaction be blamed for?牙龈增生:应该归咎于药物相互作用吗?
Indian J Pharmacol. 2017 May-Jun;49(3):257-259. doi: 10.4103/ijp.IJP_57_17.
2
On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth.药物性牙龈增生的细胞和分子机制
Open Dent J. 2017 Jul 31;11:420-435. doi: 10.2174/1874210601711010420. eCollection 2017.
3
Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases.药物性牙龈增生:一项使用自发报告系统数据库的回顾性研究
J Pharm Health Care Sci. 2017 Jul 19;3:19. doi: 10.1186/s40780-017-0088-5. eCollection 2017.
4
Assessment of reactive gingival lesions of oral cavity: A histopathological study.口腔反应性牙龈病变的评估:一项组织病理学研究。
J Oral Maxillofac Pathol. 2017 Jan-Apr;21(1):180. doi: 10.4103/jomfp.JOMFP_23_16.
5
Increased Advanced Oxidation Protein Products Generation by Cyclosporine-A and Angiotensin II in Human Gingival Fibroblasts - Ex-vivo Study.环孢素A和血管紧张素II在人牙龈成纤维细胞中增加晚期氧化蛋白产物生成的体外研究
J Clin Diagn Res. 2017 Jan;11(1):ZC49-ZC52. doi: 10.7860/JCDR/2017/22246.9183. Epub 2017 Jan 1.
6
A Clinical Evaluation of Gingival Overgrowth in Children on Antiepileptic Drug Therapy.抗癫痫药物治疗儿童牙龈增生的临床评估
J Clin Diagn Res. 2016 Jan;10(1):ZC32-6. doi: 10.7860/JCDR/2016/16443.7069. Epub 2016 Jan 1.
7
Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth.环孢素A:其在药物性牙龈增生中作用的新概念。
Dent Res J (Isfahan). 2015 Nov-Dec;12(6):499-506. doi: 10.4103/1735-3327.170546.
8
Drug-induced gingival overgrowth: The nemesis of gingiva unravelled.药物性牙龈增生:牙龈病变之谜揭晓。
J Indian Soc Periodontol. 2013 Mar;17(2):182-7. doi: 10.4103/0972-124X.113066.
9
Nifedipine-induced gingival enlargement: Correlation with dose and oral hygiene.硝苯地平引起的牙龈增生:与剂量和口腔卫生的相关性。
J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S191-3. doi: 10.4103/0975-7406.100268.
10
Connective tissue metabolism and gingival overgrowth.结缔组织代谢与牙龈增生
Crit Rev Oral Biol Med. 2004 Jun 4;15(3):165-75. doi: 10.1177/154411130401500305.